NFE2L2 and breast cancer: Here, NRF2 KD markedly decreased SLC7A11 expression and glutamate extrusion in Hs578T and MDA-MB-231 BC cells, improving cell viability upon glucose depletion while in the same conditions NRF2 activation by DMF impaired cell viability.